The global protein labeling market was valued at USD 2.4 billion in 2023 and is expected to reach USD 3.1 billion in 2026 and USD 4.3 billion by 2030, expanding at a CAGR of 8.4% from 2024 to 2030. North America accounted for the largest share of the market, representing 41.8% of global revenue in 2023.

Market expansion is being supported by rising investment in proteomics research, advances in protein analysis technologies, broader adoption of bioengineering techniques, and increasing demand for tools that support drug discovery and personalized medicine.

What Is Driving the Protein Labeling Market?

1. Rising investment in proteomics research

Proteomics has become increasingly important for understanding protein structures, functions, disease mechanisms, and therapeutic targets. Growing research funding is consequently creating demand for sophisticated protein labeling technologies.

Advances in mass spectrometry and chromatography have enabled researchers to analyze proteins with greater depth and precision. Pharmaceutical companies are also increasing their focus on proteomics because protein analysis can help identify potential drug targets and clarify mechanisms of action.

In September 2023, approximately USD 50.3 million in NIH funding was awarded for multi-omics research focused on diseases and human health. The investment supported the development of a research consortium aimed at generating and analyzing advanced multi-omics data.

The expansion of personalized medicine is another important demand driver. As researchers seek to understand differences in protein expression between individuals, advanced proteomics and protein labeling techniques are becoming increasingly valuable.

Go Deeper! Ask Prism AI

about the Global protein labeling market. Get instant answers to questions related to market sizing, growth drivers & their impact, and more.

Technology Is Increasing the Precision of Protein Labeling

Technological innovation is transforming protein labeling by improving sensitivity, specificity, flexibility, and throughput. Developments in fluorescence labeling, isotopic labeling, mass spectrometry, and other analytical technologies are expanding the capabilities of researchers.

The emergence of multiplexing techniques is particularly important because it enables the simultaneous detection of multiple proteins. Customizable labeling protocols also allow researchers to adapt experiments to different biological models and research objectives.

At the same time, new labeling agents with improved specificity and stability are expanding the range of applications available to researchers.

Bioengineering Creates New Application Opportunities

The increasing adoption of bioengineering is contributing to market growth by enabling researchers to modify proteins and develop enhanced biological functionalities.

Engineered proteins have applications across drug delivery, diagnostics, biotechnology, and other life sciences fields. As bioengineering methodologies become more sophisticated, demand is expected to increase for labeling technologies that can characterize, track, and analyze engineered proteins.

Download a free sample report or claim your copy of this full market intelligence report

Personalized Medicine Supports Long-Term Demand

The shift toward personalized medicine is increasing the need to understand individual variations in protein expression and biological pathways. Protein labeling can help researchers identify and characterize proteins associated with specific diseases or patient profiles.

This creates opportunities across areas such as biomarker discovery, therapeutic development, disease research, and diagnostics, strengthening the long-term relevance of protein labeling technologies.

COVID-19 Accelerated Demand for Protein Analysis

The COVID-19 pandemic had a positive impact on demand for protein labeling technologies within the life sciences sector. Increased research activity surrounding antiviral drug development, vaccine development, diagnostics, and disease mechanisms created additional requirements for advanced protein analysis.

Protein labeling technologies also supported the development of diagnostic tools requiring rapid and accurate identification or analysis of biological targets. Increased investment in life sciences R&D and accelerated adoption of advanced analytical technologies further contributed to demand during the pandemic.

Competitive Landscape and Market Characteristics

The protein labeling industry is characterized by a strong emphasis on technological innovation, product development, research funding, and portfolio expansion. Companies are investing in new technologies and solutions designed to improve research capabilities and outcomes while strengthening their competitive positions.

Research grants and funding for innovative R&D are also contributing to technological development and supporting demand for protein labeling solutions.

Mergers and Acquisitions

M&A activity in the market is described as moderate, with companies using acquisitions to strengthen their technology portfolios, expand capabilities, and gain competitive advantages.

A notable example occurred in January 2022, when Thermo Fisher Scientific, Inc. acquired PeproTech, Inc., a recombinant protein manufacturer that also provides recombinant cytokines for research. The acquisition strengthened Thermo Fisher Scientific's capabilities and expanded its portfolio relevant to protein research.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Product Innovation and New Solutions

Leading companies are expanding their product and service portfolios through new launches and technological developments.

In June 2023, Thermo Fisher Scientific Inc. launched the Orbitrap Astral mass spectrometer, designed to provide rapid throughput, high sensitivity, and extensive proteome coverage. Product introductions such as this are expected to contribute to the expansion of protein analysis capabilities and related services.

Regulatory and Ethical Considerations

Protein labeling applications in proteomics are influenced by regulatory requirements that overlap with broader genomics, biotechnology, and medical research frameworks.

Ethical considerations are particularly important when research involves human participants or biological samples. Researchers must follow applicable ethical standards and obtain informed consent when collecting and analyzing human-derived samples.

For clinical applications such as biomarker discovery and diagnostics, compliance with relevant medical device regulations and guidelines is also important.

Regional Expansion

The industry currently demonstrates a relatively low level of regional expansion, although opportunities are emerging as the customer base for protein labeling products and services grows.

Larger companies may acquire smaller businesses to expand their geographic presence, increase product offerings, and strengthen their competitive positions in regional markets.

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Leading Protein Labeling Companies

The competitive landscape includes several established life sciences, biotechnology, and analytical technology companies. Key participants include:

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Revvity Inc.
• Promega Corporation
• F. Hoffmann-La Roche Ltd
• LGC Ltd
• New England Biolabs
• LI-COR, Inc.
• Danaher (Cytiva)
• Jena Bioscience GmbH

Explore our dedicated business services:

Grand View Signal - Understand the key forces behind commodity price movements and strengthen your procurement strategy with a single, data-driven platform.